MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
This invention provides the human gene for Niemann-Pick Type C disease and the nucleic acid sequences corresponding to the human gene for Niemann-Pick Type C disease. More
A method of decreasing accumulation of cholesterol in arteries of humans by administering lecithin-cholesterol acyltransferase (LCAT). More
This invention concerns a position and orientation sensor designed for use with existing ultrasound instrumentation to permit the real-time measurement of blood volume flow rate within a vessel. More
A new excitation pulse sequence for the acquisition of Magnetic Resonance Imaging (MRI) data of particular usefulness in Magnetic Resonance Angiography (MRA). More
Methods for identifying a subject at increased risk for developing AMD by determining the presence of protective genotypes at either the BF/C2 locus and at the CFH locus. More
This invention relates to a computer-controlled physiological flow simulator for use in the study of vascular hemodynamics and the calibration of clinical imaging systems used to measure blood flow More
A novel combination of growth factors that may serve as a basis for promoting blood vessel formation in vitro as well as promoting of the investment of those vessels with smooth muscle cells. More
cannabidiol (CBD) was found to b effective in reducing total area covered by artherosclerotic plaques (composed of the number and/or size of atherosclerotic plaques) in aortas and in lowering triglycerides, LDL and cholesterol levels in in-vivo... More
Our client has developed and tested a unique advanced herbal formulation capable of reverting ischaemic heart conditions and complications associated with diabetic foot; as well as re-establishing blood flow in circulatory pathologies. More
Name of the inventor: Nan Wang Isolated ABCA1 protein having a mutation within its PEST domain, related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture are described. A method for increasing the formation of... More
Displaying 1..10 of 15 - per page Next page
Order by

Your selection

Therapeutic target
Cardiovascular del
Vascular del
Atherosclerosis del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us